Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for MaxCyte Inc have a median target of 633.28, with a high estimate of 766.15 and a low estimate of 500.41. The median estimate represents a 130.28% increase from the last price of 275.00.
High | 178.6% | 766.15 |
Med | 130.3% | 633.28 |
Low | 82.0% | 500.41 |
Earnings history & estimates in USD
Average growth rate | -16.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +18.61% |
More ▼